Stocks
Mutual Funds
ETFs
Pro Tools
Terminal
WealthView
Pricing
Learn More
stocks
QLINE
QLINE
569.00-3.5 (-0.60%)
22 Oct, 12:00 AM

Stock Scores

Quality Score

Score not available

Value Score

0.0 / 100

Price Momentum Score

20.0 / 100

QVM Score

Score not available

Key Metrics

Market Cap
1327.36
P/E (TTM)
-
P/B
-
P/S (TTM)
-
EV/EBITDA
-
CAPE (5Y)
-
ROE (TTM)
-
ROCE (TTM)
-
ROA (TTM)
-
Avg 3Y ROE
-
Earnings 3Y CAGR
-
Sales 3Y CAGR
-
Sales 5Y CAGR
-
Debt/Equity
-
Consensus TP
-
Strong Buy %
-
Promoter Holding
67.51
Pledged %
0.00

Share Price

Track Q-Line Biotech Ltd.'s current share price, historical price chart, 52-week high/low, and performance across different time periods.

1 Week returns: -4.90 %
Low
551.1
High
637.9
1 Month returns: -16.72 %
Low
551.1
High
710.0
1 Year returns: –
3 Year CAGR: –
5 Year CAGR: –
Note: Prices may be delayed by a few minutes. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.

Financial Snapshot

See detailed analysis

Multi-year trends for Q-Line Biotech Ltd. covering revenue, net profit, ROE, and EBITDA for a quick view of financial health over time.

Q-Line Biotech Ltd. Shareholding Pattern

Quarterly breakdown of Q-Line Biotech Ltd. ownership including promoter, FII, DII, mutual fund, and public holdings as disclosed to NSE/BSE.

Bulk, Block and Insider Trades

Recent bulk deals, block deals, and insider trading activity in Q-Line Biotech Ltd. shares as reported to NSE and BSE.

Frequently Asked Questions

What is the current share price of Q-Line Biotech Ltd.?
The current share price of Q-Line Biotech Ltd. is ₹ 569.00 as of 22 Oct 2026.
What is the market capitalisation of Q-Line Biotech Ltd.?
The market capitalisation of Q-Line Biotech Ltd. stands at ₹ 1,327.36 Cr.
What is the PE ratio of Q-Line Biotech Ltd.?
The Price-to-Earnings (PE) ratio of Q-Line Biotech Ltd. is - as of the latest trailing twelve months data.
What is the ROE and ROCE of Q-Line Biotech Ltd.?
Q-Line Biotech Ltd. has a Return on Equity (ROE) of - and a Return on Capital Employed (ROCE) of - as per the latest financial reports.
What is the 52-week high and low of Q-Line Biotech Ltd.?
The 52-week high of Q-Line Biotech Ltd. is - and the 52-week low is -.
What is the dividend yield of Q-Line Biotech Ltd.?
The dividend yield of Q-Line Biotech Ltd. is - based on the current market price.
What is the FII and DII holding in Q-Line Biotech Ltd.?
Foreign Institutional Investors (FII) hold 1.67%, Domestic Institutional Investors (DII) hold 2.61% and retail/public investors hold 20.50% of Q-Line Biotech Ltd. shares.
What sector does Q-Line Biotech Ltd. belong to?
Q-Line Biotech Ltd. operates in the Healthcare sector.
What is the beta of Q-Line Biotech Ltd.?
The beta of Q-Line Biotech Ltd. is -, indicating its price volatility relative to the broader market.
What is the RSI of Q-Line Biotech Ltd.?
The 14-day Relative Strength Index (RSI) of Q-Line Biotech Ltd. is 36.99, placing it approaching oversold territory. An RSI above 70 is considered overbought and below 30 is considered oversold.